EE463 Cost-Effectiveness of Nivolumab as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma at High Risk of Recurrence in Switzerland
| Autor: | Oniangue-Ndza, C, Kamgar, F, Schneider, RP, Teitsson, S, Knight, C |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S146-S146 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect